Gold SA - Search Results

1

Impact of pathologic features on local recurrence in penile squamous cell carcinoma after penectomy.

Gerald T, Joshi E, Gold SA, Woldu SL, Meng X, Bagrodia A, Gaston K, Margulis V. Gerald T, et al. Among authors: gold sa. Surg Oncol. 2024 Jun;54:102066. doi: 10.1016/j.suronc.2024.102066. Epub 2024 Mar 19. Surg Oncol. 2024. PMID: 38581916

2

Renal cell carcinoma with inferior vena cava thrombus: did we make progress in oncologic outcomes and complications?

Gold S, Taylor J, Margulis V. Gold S, et al. Curr Opin Urol. 2023 Mar 1;33(2):142-146. doi: 10.1097/MOU.0000000000001069. Epub 2023 Jan 9. Curr Opin Urol. 2023. PMID: 36621845 Review.

3

Uncovering a link between COVID-19 and renal cell carcinoma.

Gold SA, Margulis V. Gold SA, et al. Nat Rev Urol. 2023 Jun;20(6):330-331. doi: 10.1038/s41585-023-00749-8. Nat Rev Urol. 2023. PMID: 36914751 Free PMC article.

4

Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy.

Kenigsberg AP, Carpinito G, Gold SA, Meng X, Ghoreifi A, Djaladat H, Minervini A, Jamil M, Abdollah F, Farrow JM, Sundaram C, Uzzo R, Ferro M, Meagher M, Derweesh I, Wu Z, Porter J, Katims A, Mehrazin R, Mottrie A, Simone G, Reese AC, Eun DD, Bhattu AS, Gonzalgo ML, Carbonara U, Autorino R, Margulis V. Kenigsberg AP, et al. Among authors: gold sa. Urol Oncol. 2022 Oct;40(10):452.e17-452.e23. doi: 10.1016/j.urolonc.2022.06.006. Epub 2022 Aug 4. Urol Oncol. 2022. PMID: 35934609

5

Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI Era.

Gold SA, Goueli R, Mostardeiro TR, Carpinito GP, El-Eishy A, Mauck R, Woldu SL, Strand DW, Lotan Y, Roehrborn CG, Costa DN, Gahan JC. Gold SA, et al. Urology. 2023 Sep;179:95-100. doi: 10.1016/j.urology.2023.05.003. Epub 2023 May 13. Urology. 2023. PMID: 37182648

6

Outcomes of patients undergoing concurrent radical cystectomy and nephroureterectomy: A single-institution series.

Carpinito GP, Cook GS, Tverye AN, Gold SA, Lotan Y, Margulis V, Howard JM. Carpinito GP, et al. Among authors: gold sa. Can Urol Assoc J. 2022 Jul;16(7):E363-E369. doi: 10.5489/cuaj.7612. Can Urol Assoc J. 2022. PMID: 35230936 Free PMC article.

7

Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System.

Gold SA, Kenigsberg AP, Lotan Y. Gold SA, et al. J Urol. 2022 Jan;207(1):52-60. doi: 10.1097/JU.0000000000002175. Epub 2021 Aug 25. J Urol. 2022. PMID: 34428924

8

Emerging hormonal agents for the treatment of prostate cancer.

Bochner E, Gold S, Raj GV. Bochner E, et al. Expert Opin Emerg Drugs. 2022 Sep;27(3):301-309. doi: 10.1080/14728214.2022.2121390. Epub 2022 Sep 9. Expert Opin Emerg Drugs. 2022. PMID: 36062456 Review.

9

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.

Bloom JB, Daneshvar MA, Lebastchi AH, Ahdoot M, Gold SA, Hale G, Mehralivand S, Sanford T, Valera V, Wood BJ, Choyke PL, Merino MJ, Turkbey B, Parnes HL, Pinto PA. Bloom JB, et al. Among authors: gold sa. Urol Oncol. 2021 Oct;39(10):729.e1-729.e6. doi: 10.1016/j.urolonc.2021.02.018. Epub 2021 Mar 16. Urol Oncol. 2021. PMID: 33736975 Review.

10

The Economics of Cystoscopy: A Microcost Analysis.

Kenigsberg AP, Gold S, Grant L, Lotan Y. Kenigsberg AP, et al. Urology. 2021 Nov;157:29-34. doi: 10.1016/j.urology.2021.05.008. Epub 2021 May 16. Urology. 2021. PMID: 34010677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page